Royal Bank of Canada’s HUTCHMED HCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $40K | Sell |
2,660
-3,313
| -55% | -$48.4K | ﹤0.01% | 5593 |
|
|
2025
Q4 | $80K | Buy |
5,973
+575
| +11% | +$8.4K | ﹤0.01% | 5316 |
|
|
2025
Q3 | $85K | Buy |
5,398
+2,616
| +94% | +$43K | ﹤0.01% | 5592 |
|
|
2025
Q2 | $42K | Buy |
+2,782
| New | +$40.7K | ﹤0.01% | 5994 |
|
|
2024
Q4 | – | Sell |
-100
| Closed | -$2K | – | 7031 |
|
|
2024
Q3 | $2K | Sell |
100
-166
| -62% | -$3K | ﹤0.01% | 6642 |
|
|
2024
Q2 | $5K | Buy |
266
+163
| +158% | +$3.01K | ﹤0.01% | 6536 |
|
|
2024
Q1 | $2K | Sell |
103
-333
| -76% | -$5.05K | ﹤0.01% | 6674 |
|
|
2023
Q4 | $8K | Sell |
436
-4,118
| -90% | -$74.9K | ﹤0.01% | 6555 |
|
|
2023
Q3 | $77K | Buy |
4,554
+240
| +6% | +$3.44K | ﹤0.01% | 5544 |
|
|
2023
Q2 | $51K | Sell |
4,314
-6,201
| -59% | -$84.6K | ﹤0.01% | 5771 |
|
|
2023
Q1 | $136K | Sell |
10,515
-4,293
| -29% | -$70.4K | ﹤0.01% | 4919 |
|
|
2022
Q4 | $219K | Buy |
14,808
+1,473
| +11% | +$16.1K | ﹤0.01% | 4791 |
|
|
2022
Q3 | $117K | Sell |
13,335
-81,320
| -86% | -$1.02M | ﹤0.01% | 5200 |
|
|
2022
Q2 | $1.2M | Sell |
94,655
-39,339
| -29% | -$501K | ﹤0.01% | 3332 |
|
|
2022
Q1 | $2.53M | Buy |
133,994
+8,123
| +6% | +$207K | ﹤0.01% | 2841 |
|
|
2021
Q4 | $4.42M | Buy |
125,871
+4,958
| +4% | +$161K | ﹤0.01% | 2469 |
|
|
2021
Q3 | $4.43M | Buy |
120,913
+13,237
| +12% | +$521K | ﹤0.01% | 2394 |
|
|
2021
Q2 | $4.23M | Buy |
107,676
+15,235
| +16% | +$440K | ﹤0.01% | 2428 |
|
|
2021
Q1 | $2.61M | Buy |
92,441
+11,784
| +15% | +$376K | ﹤0.01% | 2785 |
|
|
2020
Q4 | $2.58M | Buy |
80,657
+11,223
| +16% | +$345K | ﹤0.01% | 2691 |
|
|
2020
Q3 | $2.24M | Buy |
69,434
+11,971
| +21% | +$373K | ﹤0.01% | 2596 |
|
|
2020
Q2 | $1.58M | Buy |
57,463
+7,393
| +15% | +$160K | ﹤0.01% | 2812 |
|
|
2020
Q1 | $894K | Buy |
50,070
+9,835
| +24% | +$237K | ﹤0.01% | 3120 |
|
|
2019
Q4 | $1.01M | Sell |
40,235
-682
| -2% | -$14.9K | ﹤0.01% | 3435 |
|
|
2019
Q3 | $730K | Sell |
40,917
-1,059
| -3% | -$22.1K | ﹤0.01% | 3581 |
|
|
2019
Q2 | $923K | Buy |
41,976
+12,610
| +43% | +$360K | ﹤0.01% | 3367 |
|
|
2019
Q1 | $899K | Buy |
29,366
+1,714
| +6% | +$42.7K | ﹤0.01% | 3278 |
|
|
2018
Q4 | $639K | Buy |
27,652
+27,368
| +9,637% | +$851K | ﹤0.01% | 3523 |
|
|
2018
Q3 | $9K | Buy |
284
+81
| +40% | +$2.47K | ﹤0.01% | 6026 |
|
|
2018
Q2 | $6K | Sell |
203
-6,544
| -97% | -$208K | ﹤0.01% | 5980 |
|
|
2018
Q1 | $199K | Buy |
+6,747
| New | +$240K | ﹤0.01% | 4323 |
|
Other funds holding HCM
AG
MGP
CGH
Royal Bank of Canada's HCM Position: Q1 2026 in Review
Royal Bank of Canada reduced its HUTCHMED (HCM) stake by 55% in Q1 2026, selling an estimated $48.4K and leaving 2,660 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #5593.
Royal Bank of Canada first reported a position in HCM in Q1 2018 and has held it in 31 quarters since. The position peaked at $4.43M in Q3 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.
- Royal Bank of Canada held 2,660 shares of HUTCHMED worth $40K as of Q1 2026.
- Royal Bank of Canada sold 3,313 HUTCHMED shares in Q1 2026, an estimated $48.4K.
- HUTCHMED made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #5593 holding.
- Royal Bank of Canada first reported a position in HUTCHMED in Q1 2018 and has held it in 31 quarters since.
- Royal Bank of Canada's HUTCHMED position peaked at $4.43M in Q3 2021.
- 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.
Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.